Cargando…
Nanocarriers Provide Sustained Antifungal Activity for Amphotericin B and Miltefosine in the Topical Treatment of Murine Vaginal Candidiasis
Topical drug administration is frequently used for the treatment of vaginal candidiasis; however, most formulations using this route do not provide prolonged drug release. Our aim was to evaluate the antifungal efficacy of amphotericin B (AMB) and miltefosine (MFS) incorporated in nanocarriers for s...
Autores principales: | de Bastiani, Fernanda Walt Mendes da Silva, Spadari, Cristina de Castro, de Matos, Jenyffer Kelly Rocha, Salata, Giovanna Cassone, Lopes, Luciana Biagini, Ishida, Kelly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965356/ https://www.ncbi.nlm.nih.gov/pubmed/31998264 http://dx.doi.org/10.3389/fmicb.2019.02976 |
Ejemplares similares
-
Alginate nanoparticles as non-toxic delivery system for miltefosine in the treatment of candidiasis and cryptococcosis
por: Spadari, Cristina de Castro, et al.
Publicado: (2019) -
Potential Use of Alginate-Based Carriers As Antifungal Delivery System
por: Spadari, Cristina de Castro, et al.
Publicado: (2017) -
Thermoreversible Gel-Loaded Amphotericin B for the Treatment of Dermal and Vaginal Candidiasis
por: Sosa, Lilian, et al.
Publicado: (2019) -
Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol
por: Gonçalves, Gustavo, et al.
Publicado: (2021) -
New Approaches for Cryptococcosis Treatment
por: Spadari, Cristina de Castro, et al.
Publicado: (2020)